ELGETHUN CAPITAL MANAGEMENT – Lineage Cell Therapeutics, Inc. Transaction History
ELGETHUN CAPITAL MANAGEMENT portfolio value:
$17,000
portfolio value
ELGETHUN CAPITAL MANAGEMENT quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -7K | $1.13 | 15K | |
| Q2 2022 | share | 0.00% | 0 shares | 1K | $1.58 | 15K | |
| Q1 2022 | share | 0.00% | 0 shares | -15K | $1.54 | 15K | |
| Q4 2021 | share | 0.00% | 0 shares | 0 | $2.5 | 15K | |
| Q3 2021 | share | 0.00% | 0 shares | -5K | $2.52 | 15K | |
| Q2 2021 | share | 0.00% | 0 shares | 8K | $2.85 | 15K | |
| Q1 2021 | share | 0.00% | 0 shares | 9K | $2.35 | 15K | |
| Q4 2020 | share | 0.00% | 0 shares | 12K | $1.76 | 15K | |
| Q3 2020 | share | 0.00% | 0 shares | 1K | $0.94 | 15K | |
| Q2 2020 | share | 0.00% | 0 shares | 1K | $0.87 | 15K | |
| Q1 2020 | share | 0.00% | 0 shares | -1K | $0.83 | 15K | |
| Q4 2019 | share | Increase | 0.00% | 15K shares | 13K | $0.89 | 15K |